Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 5:09 pm Purchase | 2025-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | Nantahala Capital Management, LLC | 2,449,468 2.800% | 205,149![]() (+9.14%) | Filing History |
| 2026-02-13 5:09 pm Sale | 2025-12-31 | 13G | Verastem, Inc. VSTM | Nantahala Capital Management, LLC | 3,795,473 4.720% | -830,763![]() (-17.96%) | Filing History |
| 2026-02-13 5:08 pm Purchase | 2025-12-31 | 13G | Gogo Inc. GOGO | Nantahala Capital Management, LLC | 6,792,649 5.070% | 6,792,649![]() (New Position) | Filing History |
| 2026-02-13 5:08 pm Sale | 2025-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Nantahala Capital Management, LLC | 1,953,045 4.710% | -1,232,519![]() (-38.69%) | Filing History |
| 2026-02-13 5:07 pm Purchase | 2025-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Nantahala Capital Management, LLC | 2,281,040 9.990% | 2,281,040![]() (New Position) | Filing History |
| 2026-02-13 5:07 pm Purchase | 2025-12-31 | 13G | The Hain Celestial Group, Inc. HAIN | Nantahala Capital Management, LLC | 6,528,789 7.210% | 6,528,789![]() (New Position) | Filing History |
| 2026-02-13 5:06 pm Sale | 2025-12-31 | 13G | Savara Inc. SVRA | Nantahala Capital Management, LLC | 7,344,783 3.610% | -1,430,592![]() (-16.30%) | Filing History |
| 2026-02-13 5:06 pm Purchase | 2025-12-31 | 13G | Fox Factory Holding Corp. FOXF | Nantahala Capital Management, LLC | 2,188,300 5.240% | 2,188,300![]() (New Position) | Filing History |
| 2026-02-13 5:06 pm Purchase | 2025-12-31 | 13G | Opus Genetics, Inc. IRD | Nantahala Capital Management, LLC | 7,123,506 9.990% | 873,207![]() (+13.97%) | Filing History |
| 2026-02-13 5:06 pm Sale | 2025-12-31 | 13G | Establishment Labs Holdings Inc. ESTA | Nantahala Capital Management, LLC | 987,689 3.500% | -985,803![]() (-49.95%) | Filing History |
| 2026-02-13 5:05 pm Purchase | 2025-12-31 | 13G | Korro Bio, Inc. KRRO | Nantahala Capital Management, LLC | 600,000 6.370% | 600,000![]() (New Position) | Filing History |
| 2026-02-13 5:05 pm Purchase | 2025-12-31 | 13G | Elutia Inc. ELUT | Nantahala Capital Management, LLC | 4,124,854 9.990% | 435,787![]() (+11.81%) | Filing History |
| 2026-02-13 5:05 pm Sale | 2025-12-31 | 13G | Immunic, Inc. IMUX | Nantahala Capital Management, LLC | 10,378,406 8.220% | -256,159![]() (-2.41%) | Filing History |
| 2026-02-13 5:05 pm Purchase | 2025-12-31 | 13G | Edesa Biotech, Inc. EDSA | Nantahala Capital Management, LLC | 855,583 9.990% | 155,095![]() (+22.14%) | Filing History |
| 2026-02-13 5:04 pm Purchase | 2025-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT | Nantahala Capital Management, LLC | 7,037,916 5.680% | 1,739,292![]() (+32.83%) | Filing History |
| 2026-02-13 5:04 pm Purchase | 2025-12-31 | 13G | DarioHealth Corp. DRIO | Nantahala Capital Management, LLC | 688,673 9.990% | 119,829![]() (+21.07%) | Filing History |
| 2026-02-13 5:04 pm Purchase | 2025-12-31 | 13G | Herbalife Nutrition Ltd. HLF | Nantahala Capital Management, LLC | 8,681,857 8.400% | 1,559,559![]() (+21.90%) | Filing History |
| 2026-02-13 5:03 pm Sale | 2025-12-31 | 13G | DHI Group, Inc. DHX | Nantahala Capital Management, LLC | 2,374,027 5.030% | -2,579![]() (-0.11%) | Filing History |
| 2026-02-13 5:03 pm Purchase | 2025-12-31 | 13G | BiomX Inc. PHGE | Nantahala Capital Management, LLC | 156,696 9.990% | 156,696![]() (New Position) | Filing History |
| 2026-02-13 5:02 pm Purchase | 2025-12-31 | 13G | Bioventus Inc. BVS | Nantahala Capital Management, LLC | 6,047,403 9.030% | 766,561![]() (+14.52%) | Filing History |

